172 related articles for article (PubMed ID: 22827960)
1. Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer.
Shi L; Wu C; Wu J; Zhou W; Ji M; Zhang H; Zhao J; Huang Y; Pei H; Li Z; Ju J; Jiang J
Radiat Oncol; 2012 Jul; 7():114. PubMed ID: 22827960
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of CT-guided (125)I seed brachytherapy for postoperative locoregional recurrence in patients with non-small cell lung cancer.
Huo X; Wang H; Yang J; Li X; Yan W; Huo B; Zheng G; Chai S; Wang J; Guan Z; Yu Z
Brachytherapy; 2016; 15(3):370-380. PubMed ID: 26944267
[TBL] [Abstract][Full Text] [Related]
3. Palliative treatment of pelvic bone tumors using radioiodine (
Wang C; Chen Z; Sun W; Yasin Y; Zhang C; Ma X; Chen J; Shen J; Hua Y; Cai Z
World J Surg Oncol; 2016 Nov; 14(1):294. PubMed ID: 27884196
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-guided 125I seed interstitial implantation in the treatment of recurrent ovarian cancer.
Wang Y; Zhang W; Liu P; Guo Z; Ni H
Int J Gynecol Cancer; 2014 Oct; 24(8):1414-9. PubMed ID: 25248113
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
6. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.
Yao L; Jiang Y; Jiang P; Wang H; Meng N; Qu A; Tian S; Sun H; Liu C; Wang J; Zhang K
Brachytherapy; 2015; 14(5):662-9. PubMed ID: 26138110
[TBL] [Abstract][Full Text] [Related]
7. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and dosimetry analysis of CT-guided
Wang L; Wang H; Jiang Y; Ji Z; Guo F; Jiang P; Li X; Chen Y; Sun H; Fan J; Li W; Li X; Wang J
Radiat Oncol; 2020 Jul; 15(1):179. PubMed ID: 32711542
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
Qu A; Jiang P; Sun H; Jiang W; Jiang Y; Tian S; Wang J
J Gynecol Oncol; 2019 Jan; 30(1):e9. PubMed ID: 30479093
[TBL] [Abstract][Full Text] [Related]
10. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
11. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
12. CT-guided implantation of (125)I seeds (permanent brachytherapy) for metastatic tumors of the hepatic portal system: Effectiveness and safety in 13 patients.
Li J; Xie Q; Wang W; Hua Y; Cheng Y; Li L; Zhu X
Brachytherapy; 2016; 15(2):224-30. PubMed ID: 26832671
[TBL] [Abstract][Full Text] [Related]
13. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-magnetic resonance imaging fusion-guided iodine-125 seed implantation for single malignant brain tumor: Feasibility and safety.
Liu SF; Lu J; Wang H; Han Y; Wang DF; Yang LL; Li ZX; Hu XK
J Cancer Res Ther; 2019; 15(4):818-824. PubMed ID: 31436237
[TBL] [Abstract][Full Text] [Related]
15. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
16. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
17. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
[TBL] [Abstract][Full Text] [Related]
18. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
19. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
Kozak MM; Koenig JL; von Eyben R; Kidd EA
Pract Radiat Oncol; 2019 Mar; 9(2):e164-e171. PubMed ID: 30395974
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
Geisel D; Denecke T; Collettini F; Grieser C; Wust P; Thuss-Patience P; Hamm B; Gebauer B
Anticancer Res; 2012 Dec; 32(12):5453-8. PubMed ID: 23225451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
